Valuation: Guided Therapeutics Inc

Market Cap 27.03M 23.63M 21.72M 20.24M 38.39M 2.57B 38.98M 261M 101M 1.27B 101M 99.28M 4.36B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 29.91M 26.14M 24.03M 22.4M 42.48M 2.85B 43.12M 288M 112M 1.4B 112M 110M 4.82B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.97%+2.03%+21.92%+0.83% 195B
+5.87%+5.27%-21.76%+26.78% 151B
+2.17%+0.89%-2.59%-16.42% 140B
+4.83%+2.06%-56.73%-15.69% 67.09B
+2.59%+3.95%+22.89%+3.15% 54.34B
+0.03%+2.19%-25.48%-31.00% 44.63B
+0.31%+1.30%+8.30%+43.25% 37.24B
-2.02%-3.91%+7.67%+9.53% 36.91B
+4.24%+4.66%-18.42%-2.34% 30.24B
Average +2.22%+2.74%-7.13%+2.01% 83.99B
Weighted average by Cap. +2.78%+3.44%-4.03%+2.02%

Financials

2024 2025
Net sales 7K 6.12K 5.62K 5.24K 9.94K 666K 10.09K 67.51K 26.25K 328K 26.28K 25.71K 1.13M 767K 671K 616K 574K 1.09M 73.03M 1.11M 7.4M 2.88M 35.9M 2.88M 2.82M 124M
Net income -2.42M -2.11M -1.94M -1.81M -3.43M -230M -3.49M -23.31M -9.06M -113M -9.07M -8.88M -390M -3.2M -2.79M -2.57M -2.39M -4.54M -304M -4.61M -30.82M -11.98M -150M -12M -11.74M -515M
Net Debt 1.77M 1.55M 1.42M 1.33M 2.52M 169M 2.55M 17.08M 6.64M 82.89M 6.65M 6.5M 286M 2.88M 2.51M 2.31M 2.15M 4.08M 274M 4.15M 27.74M 10.78M 135M 10.8M 10.56M 464M
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-